Valproic acid hepatic fatalities: revised table.
Valproic acid hepatic fatalities. III. U.S. experience since 1986.
Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy
Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
Histone deacetylase is a target of valproic acid-mediated cellular differentiation
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhi...
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukem...
Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S et al.. Valproic acid defines a novel class of HDAC inhibitors induc...